HIGHLIGHTS
- who: Angeline Ginzac from the Comillas Pontifical University, Spain have published the research: Adapted Physical Activity for Breast Cancer Patients Treated with Neoadjuvant Chemotherapy and Trastuzumab Against HER2 (APACAN2): A Protocol for a Feasibility Study, in the Journal: (JOURNAL)
- what: The aim of the APACAN2 trial is to demonstrate the feasibility of a home-based adapted physical activity (APA) program for patients with HER2 positive breast cancer receiving neoadjuvant chemotherapy. In to this intervention, the authors aim to encourage physical activity from the beginning of the treatment by proposing a physical activity program at home . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.